E*I complex

Slow-binding inhibitors operate by one of two mechanisms. Either the inhibitor binds slowly in an initial step, or the initial binding step occurs quickly, followed by a slow rearrangement of the E-I complex. 

Certain substances known as competitive inhibitors, symbolized I, may lower the catalytic efficiency of the enzyme (or other catalyst) by binding to it. Consider that the E I complex has a dissociation constant K. ... 

In a two-step enzyme isomerization mechanism, as in scheme C, the affinity of the inhibitor encounter complex and the affinity of the final E I complex are reflected in the diminutions of v, and of vs, respectively, that result from increasing concen-... 

Let us assume that for a particular enzyme-inhibitor pair, association is diffusion limited so that k, is I O9 M s1. Fixing k n at this value, and using Equation (7.26), we can determine the value of koB for different values of Kn as summarized in Table 7.3 (this is taken from the more comprehensive table presented in Chapter 2). We have already seen examples in Chapter 6 of compounds with A) values (or Kf values) in the lOnM to lOpM range for which the half-life for binary complex dissociation is far longer than 2 hours. For example, we saw that inhibition of COX2 by DuP697 resulted in a final E I complex with Kf = 5 nM and the lm for complex... 

Enzyme inhibition by an extremely tight-binding inhibi-tor When the substrate(s), regardless of the detailed mode of inhibition, has (have) a negligible effect on the formation of enzyme-inhibitor (E-I) complex, the net result is depletion i.e., the removal of enzyme by the inhibitor from the reaction). The observed kinetic pattern is identical to the simple noncompetitive inhibition case the substrate and the inhibitor do not affect each other s binding, because only V sk is changed due to reduced enzyme concentration, while remains unaltered. 

A serpin is a xerine proteinase inhibitor that forms cata-lytically inactive complexes which, after cleavage of the pi pif linkage, releases the inhibitor very slowly. O Malley et al. recently demonstrated that antichymo-trypsin (1) binds to chymotrypsin (E) to form an E I complex via a three-step mechanism ... 

One of the second type of inhibitor analogs which cause a time-dependent inactivation of alanine racemase is (l-aminoethyl)phosphonic acid, the phosphonate analog of alanine (Ala-P). Ala-P effectively and specifically inactivates alanine racemases from Grampositive bacteria (Bacillus, Staphylococcus, Streptococcus), and serves as a reversible inhibitor of Gram-negative bacterial (Escherichia, Salmonella) alanine racemase.47 53 The mechanism of inhibition was studied with B. stearothermophihis alanine racemase.47 The d- or L-Ala-P leads to an E-I complex with a Ki value of 1 mM, then is slowly isomerized (A nac<=6-9 min-1) to a stoichiometric enzyme complex (E-I ). The Ed dissociates extremely slowly with the... 

The components Ks and K denote equilibrium constants for the E-S and E-I complexes, respectively. Equation 7.92, when plotted as l/Vp versus 1/[S] for various quantities of inhibitor I, produces a straight line for each I with a common y intercept, but a different slope. The slope would differ from that of a system without I by the factor... 

Most of the enzyme-inhibitory compounds described in this book act by reversibly binding to the target enzyme to form an inactive enzyme—inhibitor (E—I) complex ... 

INDO (11, 23). To attain maximal inhibition in vitro, INDO must be preincubated with COX for at least 10 minutes before the addition of substrate (9). However, maximal inhibition of COX-1 by 8 and 9 can be achieved by a 30 second preincubation with the protein (23). The potency of inhibition once again is determined by the dissociation of the E—I complex. As with INDO, k 2 could not be detected for 9, and substrate cannot compete efficiently with INDO or 9 for the oxygenase site, even after prolonged incubations. In contrast, k-2 for 8 is measurable and of the same order of magnitude as 2- Even when COX-1 is preincubated with 8, most enzymatic activity is recovered following incubation with substrate. 

When the equilibrium for reversible E-I complex formation ( Ti) is rapid, and the rate of dissociation of the E-I complex (fcoff) is fast relative to kjuact (the most common situation), then kinact is the rate-determining step, and time-dependent loss of enzyme activity occurs. Under these conditions, when [I] [Eq], then Kitz and Wilson (65) described kapp by Equation 19. Two... 

To determine the Ki and kmact values, first a plot of the log of the enzyme activity versus time is constructed (Fig. 16a). The rate of inactivation is proportional to low concentrations of the inactivator, but becomes independent at high concentrations. In these cases, the inactivator reaches enzyme saturation (just as substrate saturation occurs during catalytic turnover). Once all of the enzyme molecules are in the E-I complex, the addition of more inactivator does not affect the rate of the inactivation reaction. The half-lives for inactivation (fi/2) at each inactivator concentration (lines a-e in Fig. 16a) are determined. The fi/2 at any inactivator concentration equals log 2/kina( t,appf in the limiting case of infinite inactivator concentration, fi/2 = 0.693/kiiiact (log 2 = 0.693). A replot of these half-lives versus the inverse of the inactivator concentration, referred to as a Kitz and Wilson replot, is constructed to obtain the K and kjuact values (Fig. 16b). 

Transition-state inhibitors, especially those with peptidyl or peptidomimetic extensions, are slow-binding inhibitors, and the protease-inhibitor binding mechanism includes one or more weakly bound intermediates before the formation of the tightly bound E I complex. This slow-binding inhibition is a hallmark of inhibitors that bind in the active site in a substrate-like manner. In this way, transition-state analogs mimic the association... 

For slow-tight-binding inhibitors, is very small and formation of the E. I complex is essentially irreversible. Use of Equation 17.28 ensures that depletion of free enzyme and free inhibitor by formation of the E. I complex is taken into account. 

In mechanism B, the more common mechanism for slow-bindinginhibition (80), the initial equilibrium between the enzyme, inhibitor, and the E I complex is fast. However, there is a subsequent slow rearrangement to form the final, more stable enzyme-inhibitor complex (E. I ) (Equation 17.29). 

Here the dissociation constant for the initial E I complex is still but there is... 

To observe the slow onset of inhibition and the E. I complex, iiTj must be smaller than and smaller than 4. However, if is considerably smaller than 4, then the formation of the E. I complex will be effectively irreversible (i.e., the inhibitor is of the slow-tight-binding variety). Under those circumstances it will again be necessary to take depletion of free enzyme and free inhibitor into account when determining iiTi and K (78). 

Enzyme inhibitors are species that cause a decrease in the activity of an enzyme. Inhibitors usually interact with the enzyme itself, forming enzyme-inhibitor (E I) complexes, but in a few cases, the inhibition mechanism involves reaction with one of the substrates. Inhibition is considered to be reversible if the enzyme recovers its activity when the inhibitor is removed, and irreversible if the inhibitor causes a permanent loss of activity. Reversible inhibition affects the specific activity and apparent Michaelis-Menten parameters for the enzyme, while irreversible inhibition (where the E I complex formation is irreversible) simply decreases the concentration of active enzyme present in the sample. A well-known example of irreversible inhibition is the effect of nerve gas on the enzyme cholinesterase. 

---